154 related articles for article (PubMed ID: 24718812)
1. Role of the p.E66Q variant of GLA in the progression of chronic kidney disease.
Watanabe H; Goto S; Miyashita A; Maruyama H; Wakasugi M; Yokoseki A; Kuwano R; Narita I
Clin Exp Nephrol; 2015 Apr; 19(2):225-30. PubMed ID: 24718812
[TBL] [Abstract][Full Text] [Related]
2. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yazaki M; Sakurai A; Endo F; Fukushima Y; Ikeda SI
Eur J Neurol; 2014; 21(1):49-56. PubMed ID: 23724928
[TBL] [Abstract][Full Text] [Related]
3. The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.
Kikumoto Y; Sugiyama H; Morinaga H; Inoue T; Takiue K; Kitagawa M; Saito D; Takatori Y; Kinomura M; Kitamura S; Akagi S; Sada K; Nakao K; Maeshima Y; Kitayama H; Makino H
Clin Nephrol; 2012 Sep; 78(3):224-9. PubMed ID: 22874111
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns.
Lee BH; Heo SH; Kim GH; Park JY; Kim WS; Kang DH; Choe KH; Kim WH; Yang SH; Yoo HW
J Hum Genet; 2010 Aug; 55(8):512-7. PubMed ID: 20505683
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients.
Doi K; Noiri E; Ishizu T; Negishi K; Suzuki Y; Hamasaki Y; Honda K; Fujita T; Tsukimura T; Togawa T; Saito S; Sakuraba H
J Hum Genet; 2012 Sep; 57(9):575-9. PubMed ID: 22695894
[TBL] [Abstract][Full Text] [Related]
6. Pathological Renal Findings of Chronic Renal Failure in a Patient with the E66Q Mutation in the α-galactosidase A Gene.
Satomura A; Fujita T; Nakayama T; Kusano H; Takayama E; Hamada H; Maruyama T
Intern Med; 2015; 54(14):1819-24. PubMed ID: 26179544
[TBL] [Abstract][Full Text] [Related]
7. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.
Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E
Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males.
Oliveira JP; Nowak A; Barbey F; Torres M; Nunes JP; Teixeira-E-Costa F; Carvalho F; Sampaio S; Tavares I; Pereira O; Soares AL; Carmona C; Cardoso MT; Jurca-Simina IE; Spada M; Ferreira S; Germain DP
Eur J Med Genet; 2020 Feb; 63(2):103703. PubMed ID: 31200018
[TBL] [Abstract][Full Text] [Related]
10. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
[TBL] [Abstract][Full Text] [Related]
11. GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing.
Peng H; Xu X; Zhang L; Zhang X; Peng H; Zheng Y; Luo S; Guo H; Xia K; Li J; Yao H; Hu Z
Gene; 2016 Jan; 575(2 Pt 1):363-7. PubMed ID: 26456105
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients.
Nagamatsu K; Sekijima Y; Nakamura K; Nakamura K; Hattori K; Ota M; Shimizu Y; Endo F; Ikeda SI
J Hum Genet; 2017 Jul; 62(7):665-670. PubMed ID: 28275245
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
Atsukawa M; Tsubota A; Toyoda H; Takaguchi K; Kondo C; Okubo T; Hiraoka A; Michitaka K; Fujioka S; Uojima H; Watanabe T; Ikeda H; Asano T; Ishikawa T; Matsumoto Y; Abe H; Kato K; Tsuji K; Ogawa C; Shimada N; Iio E; Mikami S; Tanaka Y; Kumada T; Iwakiri K
J Gastroenterol Hepatol; 2019 Feb; 34(2):364-369. PubMed ID: 30144366
[TBL] [Abstract][Full Text] [Related]
14. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease: biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution.
Togawa T; Tsukimura T; Kodama T; Tanaka T; Kawashima I; Saito S; Ohno K; Fukushige T; Kanekura T; Satomura A; Kang DH; Lee BH; Yoo HW; Doi K; Noiri E; Sakuraba H
Mol Genet Metab; 2012 Apr; 105(4):615-20. PubMed ID: 22305854
[TBL] [Abstract][Full Text] [Related]
16. Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
Maruyama H; Takata T; Tsubata Y; Tazawa R; Goto K; Tohyama J; Narita I; Yoshioka H; Ishii S
Clin J Am Soc Nephrol; 2013 Apr; 8(4):629-36. PubMed ID: 23307880
[TBL] [Abstract][Full Text] [Related]
17. Comment on 'p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males'.
Satomura A; Yanai M; Fujita T; Nakayama T
Eur J Neurol; 2014 Aug; 21(8):e62. PubMed ID: 25039766
[No Abstract] [Full Text] [Related]
18. High-risk screening for Fabry disease in hemodialysis patients in Chiba Prefecture, Japan.
Imasawa T; Murayama K; Sawada T; Hirose M; Takayanagi M; Nakamura K
Clin Exp Nephrol; 2023 Mar; 27(3):288-294. PubMed ID: 36574104
[TBL] [Abstract][Full Text] [Related]
19. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
Sugimoto M; Takahashi N; Niimi K; Kodama A; Banno H; Komori K
J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
[TBL] [Abstract][Full Text] [Related]
20. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
